Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Cresilon, Inc.

Cresilon, Inc.

Stage unknownBrooklyn, NYcresilon.comBiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
5
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2
Financing history
5 rounds
  1. Apr 24, 2026
    Form D equity offering · $5.0M (form d sold) · 21 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Cresilon, Inc. filed Form D: $4,997,000 sold of $25,000,000, Biotechnology”
  2. Nov 21, 2025
    Form D equity offering · $6.7M (form d sold) · 55 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Cresilon, Inc. filed Form D: $6,683,401 sold of $6,716,808, Biotechnology”
  3. Apr 11, 2025
    Form D equity offering · $17.2M (form d sold) · 95 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Cresilon, Inc. filed Form D: $17,172,969 sold of $34,797,261, Biotechnology”
  4. Apr 18, 2024
    Form D equity offering · $25.0M (form d sold) · 237 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Cresilon, Inc. filed Form D: $24,999,967 sold of $25,000,000, Biotechnology”
  5. Aug 3, 2023
    Form D equity offering · $17.2M (form d sold) · 309 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Cresilon, Inc. filed Form D: $17,243,350 sold of $38,006,240, Biotechnology”
Investors on record
2 edges
People
3 officers, 1 directors
Timeline
7
  1. Sep 16, 2026
    Cresilon, Inc. no longer listed on Innovating Capital Management, LLC's portfolio page
    Removed from portfolio page Inference Venture organization websites (about, team, portfolio, thesis, news pages)
  2. Jun 26, 2026
    Cresilon, Inc. filed Form D/A: $28,999,199 sold of $29,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  3. Apr 29, 2026
    Cresilon, Inc. filed Form D: $4,997,000 sold of $25,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  4. Dec 8, 2025
    Cresilon, Inc. filed Form D: $6,683,401 sold of $6,716,808, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  5. Sep 5, 2025
    Cresilon, Inc. filed Form D: $17,172,969 sold of $34,797,261, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  6. Jan 31, 2025
    Cresilon, Inc. filed Form D: $24,999,967 sold of $25,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  7. Oct 8, 2024
    Cresilon, Inc. filed Form D: $17,243,350 sold of $38,006,240, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
86 observations
Every observation on this company